health

Painkillers: The ‘popular’ painkiller that may 'triple' the risk of stroke – BMJ study


The team also looked at COX-2 inhibitors, a new generation anti-inflammatory drug.

To evaluate the effects of both drugs, researchers analysed randomised control trials comparing NSAID, with other forms of the anti-inflammatory pill or placebo.

A total of thirty-one trials were completed, with 116,429 patients involved.

The results revealed that rofecoxib and lumiracoxib were associated with twice the risk of heart attack when compared with placebo.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more